FAQs

I am unable to login using the Temporary Password I received via email.
I did not receive the email nominating me to serve as a reference writer or the email containing my temporary password.
I was asked to provide letters for several applicants, but one is not showing up on my list of applicants. How can I submit the letter?

Reference letter requests are associated with the reference writer's e-mail address. If two applicants list different e-mail addresses for the same reference, and the reference logs in to submit a letter using the e-mail address listed by the first applicant, the second applicant will not show up on that reference's list of applicants. In this case, you should repeat the first-time login process using the e-mail address listed by the "missing" applicant.

What are the formatting requirements for the letters of reference?

Letters of reference are limited to a maximum of 2 pages in length. Please note that the FastLane module will not accept letters that are longer than 2 pages. The letters must be written using standard 8.5" x 11" page size, 12-point, Times New Roman font or Computer Modern (LaTeX) font, 1" margins on all sides. Letters must be single spaced or greater and character spacing should use normal (100%) single-line space option. The letters should also be signed and submitted on professional letterhead.

Is there a page limit for letters of reference?

Letters of reference are limited to a maximum of 2 pages in length. Please note that the FastLane module will not accept letters that are longer than 2 pages.

Girls receive hands-on opportunities to engage in science activities through BUGS--Bringing Up Girls in Science Program.

Fellow Carlos J. Cela, from the Bioelectromagnetics Laboratory at North Carolina State University, works on the modeling of electrical interactions between implantable retinal stimulators and neural tissue, which has application to the development of an artificial retina to restore partial vision to the blind. Retinal implants aim to restore vision to the blind suffering from degenerative retinal diseases, including Age-related Macular Degeneration and Retinitis Pigmentosa.